Prellis Biologics · 2 days ago
Part-Time Lab & CAD Technician (Optics / 3D Printing)
Prellis Biologics is a pre-IPO biotech located in Berkeley, CA, seeking a part-time Lab & CAD Technician to support holographic 3D printing and lab workflows. The role involves creating 3D CAD designs, converting models for printing, operating 3D printing runs, and supporting printer development.
3D PrintingBiopharmaBiotechnologyTherapeutics
Responsibilities
Create 3D CAD designs for printed parts (SolidWorks)
Convert 3D models into printer-ready instructions and setups
Operate holographic 3D printing runs (start/stop, basic monitoring, documentation)
Support printer development and iterative improvements as time allows
Qualification
Required
Create 3D CAD designs for printed parts (SolidWorks)
Convert 3D models into printer-ready instructions and setups
Operate holographic 3D printing runs (start/stop, basic monitoring, documentation)
Support printer development and iterative improvements as time allows
Preferred
CAD experience (SolidWorks strongly preferred)
Experience working in an optical lab environment
Experience in a chemistry or bio lab (sample prep, basic lab practices, cleanliness/organization)
Availability up to 10 hours/week
Comfortable coming onsite for a few hours on weekends as needed
Strong attention to detail and ability to follow protocols/SOPs
Company
Prellis Biologics
Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.
H1B Sponsorship
Prellis Biologics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2023 (2)
Funding
Current Stage
Growth StageTotal Funding
$79.37MKey Investors
Celesta CapitalKhosla VenturesTrue Ventures
2025-03-10Series C
2023-11-17Series C
2022-08-10Series C· $35M
Recent News
Corridor Business Journal
2025-11-26
Company data provided by crunchbase